ENTA : Insider Transactions for Enanta Pharmaceuticals Inc | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Enanta Pharmaceuticals Inc (ENTA)

$13.56

0.18 (1.31%) as of 4:30 Wed 5/1

Download

Exchange:

N/A

Security Type:

N/A

Shares Out:

20,070,000

Market Cap:

272.15(M)

Last Volume:

0

Avg Vol:

0

52 Week Range:

$8.18 - $37.51

Level I Sector:

Health Care

Level II Sector:

Drugs

Level III Sector:

Biotechnology

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


6 Months 1 Year 2 Year

Company Profile Enanta Pharmaceuticals is a biotechnology company that discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Co.'s wholly-owned research and development programs are in virology, namely respiratory syncytial virus, hepatitis B virus, severe acute respiratory syndrome coronavirus 2, and human metapneumovirus. Two protease inhibitors developed through Co.'s Collaborative Development and License Agreement with AbbVie Inc. (AbbVie) have been clinically tested, manufactured, and commercialized by AbbVie as part of its combination regimens for hepatitis C virus. Co. also develops Farnesoid X receptor agonists for NASH.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	0	34,545	34,545	121,822
Total Sell Value	$0	$324,869	$324,869	$4,278,788
Total People Sold	0	8	8	8
Total Sell Transactions	0	8	8	13
End Date	2024-02-01	2023-10-31	2023-05-02	2022-05-02

Adjust Filter Settings

Records found: 293

Page 10 of 12

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Sr. VP & CSO

• – –

2018-02-12

4

A

$0.00

$0

D/D

8,869

312,586

-

Sr. VP & Chief Medical Officer

• – –

2018-02-12

4

D

$76.85

$197,184

D/D

(2,566)

7,270

-

Sr. VP & Chief Medical Officer

• – –

2018-02-12

4

A

$0.00

$0

D/D

8,528

9,836

-

President and CEO

• • –

2018-02-12

4

D

$76.85

$855,439

D/D

(11,132)

653,026

-

President and CEO

• • –

2018-02-12

4

A

$0.00

$0

D/D

29,337

664,158

-

Senior Vice President

• – –

2018-02-12

4

D

$76.85

$158,685

D/D

(2,065)

6,127

-

Senior Vice President

• – –

2018-02-12

4

A

$0.00

$0

D/D

6,822

8,192

-

Gardiner Nathaniel S.

Sr. VP & General Counsel

• – –

2018-02-08

4

OE

$34.70

$149,210

D/D

4,300

7,570

-

Treasurer and CFO

• – –

2017-04-11

4

OE

$2.97

$87,058

D/D

29,274

91,979

-

Chief Scientific Officer

• – –

2017-02-13

4

D

$29.82

$32,170

D/D

(1,079)

303,717

-

Chief Scientific Officer

• – –

2017-02-13

4

A

$0.00

$0

D/D

2,920

304,796

-

Senior Vice President

• – –

2017-02-13

4

D

$29.82

$24,746

D/D

(830)

1,370

-

Senior Vice President

• – –

2017-02-13

4

A

$0.00

$0

D/D

2,200

2,200

-

Gardiner Nathaniel S.

Sr. VP & General Counsel

• – –

2017-02-13

4

D

$29.82

$24,746

D/D

(830)

3,270

-

Gardiner Nathaniel S.

Sr. VP & General Counsel

• – –

2017-02-13

4

A

$0.00

$0

D/D

2,200

4,100

-

Treasurer and CFO

• – –

2017-02-13

4

D

$29.82

$29,249

D/D

(981)

62,705

-

Treasurer and CFO

• – –

2017-02-13

4

A

$0.00

$0

D/D

2,600

63,686

-

President and CEO

• • –

2017-02-13

4

D

$29.82

$67,919

D/D

(2,278)

634,821

-

President and CEO

• • –

2017-02-13

4

A

$0.00

$0

D/D

6,800

637,099

-

Sr. VP & Chief Medical Officer

• – –

2017-02-13

4

D

$29.82

$23,613

D/D

(792)

1,308

-

Sr. VP & Chief Medical Officer

• – –

2017-02-13

4

A

$0.00

$0

D/D

2,100

2,100

-

Chief Scientific Officer

• – –

2017-01-04

4

AS

$35.09

$488,505

D/D

(13,921)

301,876

-

Chief Scientific Officer

• – –

2016-11-29

4

S

$31.44

$437,609

D/D

(13,921)

315,797

-

President and CEO

• • –

2016-06-10

4

OE

$2.97

$123,848

D/D

41,645

630,299

-

Gardiner Nathaniel S.

Sr. VP & General Counsel

• – –

2016-05-11

4

B

$24.45

$12,223

D/D

500

1,900

2.74

-

293 Records found	Previous 10 11 12	Page 10 of 12

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.